Gregory L Cvetanovich1, Adam B Yanke2, Frank McCormick2, Bernard R Bach2, Brian J Cole2. 1. Division of Sports Medicine, Department of Orthopedic Surgery, Rush Medical College of Rush University, Rush University Medical Center, Chicago, Illinois, U.S.A.. Electronic address: gregory.cvetanovich@gmail.com. 2. Division of Sports Medicine, Department of Orthopedic Surgery, Rush Medical College of Rush University, Rush University Medical Center, Chicago, Illinois, U.S.A.
Abstract
PURPOSE: The purpose of this study was to investigate the incidence of meniscal allograft transplantation (MAT) in the United States from 2007 to 2011 and to analyze trends in MAT using a large database of privately insured non-Medicare patients. METHODS: Patients who underwent MAT (Current Procedural Terminology [CPT] code 29868) from 2007 to 2011 were identified using the PearlDiver Private Payer Database. Demographic and use data available in the database were extracted for patients who underwent MAT. Statistical analysis involved Student t tests, χ-square tests, and linear regression analyses, with statistical significance set at P < .05. RESULTS: The PearlDiver database allowed analysis of approximately 25.4 million patients per year during the years 2007 to 2011 (approximately 9% of the US population younger than 65 years). From 2007 to 2011, there were a total of 302 MAT procedures, for an incidence of 0.24 MAT procedures per year per 100,000 patients. There was no statistically significant increase in MAT procedures over time (P = .36). There was a higher incidence of MAT in male patients (0.26) than in female patients (0.19) (P = .001). There was a higher incidence of MAT in patients aged 25 to 34 years (0.40) and in those younger than 25 years (0.30) compared with older patients (P < .001), with 9.7% of MAT procedures being performed in patients younger than age 35 years. CONCLUSIONS: MAT was an uncommon procedure, with no change in its incidence from 2007 to 2011. MAT procedures were performed more commonly in patients younger than 35 years and in male patients. LEVEL OF EVIDENCE: Level IV, descriptive epidemiology study.
PURPOSE: The purpose of this study was to investigate the incidence of meniscal allograft transplantation (MAT) in the United States from 2007 to 2011 and to analyze trends in MAT using a large database of privately insured non-Medicare patients. METHODS:Patients who underwent MAT (Current Procedural Terminology [CPT] code 29868) from 2007 to 2011 were identified using the PearlDiver Private Payer Database. Demographic and use data available in the database were extracted for patients who underwent MAT. Statistical analysis involved Student t tests, χ-square tests, and linear regression analyses, with statistical significance set at P < .05. RESULTS: The PearlDiver database allowed analysis of approximately 25.4 million patients per year during the years 2007 to 2011 (approximately 9% of the US population younger than 65 years). From 2007 to 2011, there were a total of 302 MAT procedures, for an incidence of 0.24 MAT procedures per year per 100,000 patients. There was no statistically significant increase in MAT procedures over time (P = .36). There was a higher incidence of MAT in male patients (0.26) than in female patients (0.19) (P = .001). There was a higher incidence of MAT in patients aged 25 to 34 years (0.40) and in those younger than 25 years (0.30) compared with older patients (P < .001), with 9.7% of MAT procedures being performed in patients younger than age 35 years. CONCLUSIONS:MAT was an uncommon procedure, with no change in its incidence from 2007 to 2011. MAT procedures were performed more commonly in patients younger than 35 years and in male patients. LEVEL OF EVIDENCE: Level IV, descriptive epidemiology study.
Authors: Thomas L Sanders; Ayoosh Pareek; Vishal S Desai; Timothy E Hewett; Bruce A Levy; Michael J Stuart; Diane L Dahm; Aaron J Krych Journal: Am J Sports Med Date: 2018-08-20 Impact factor: 6.202